The collection of spine and pelvis specific movement parameters during gait of competitive athletes using videorasterstereography
- Conditions
- Time of maximum pelvic rotation in the gait
- Registration Number
- DRKS00026187
- Lead Sponsor
- niversitätsmedizin MainzZentrum für Orthopädie und Unfallchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
1. subjects of both biological sexes between 18 and 30 years.
2. test persons who have been practicing competitive sports for a total of at least 12 months with a training frequency of 5 units per week for at least 1 hour each. Training breaks, such as vacation days or injury breaks, do not count.
3. 50 % of the test persons should only participate in sports that include running as an important component, such as long-distance runners, sprinters, or soccer players.
4. 50 % of the test persons can participate in different sports in which running is required for the exercise of the discipline.
1. subjects who have received surgical treatment to the musculoskeletal system in the last 6 months or have had an injury that resulted in a training break of > 3 weeks.
2. subjects who have suffered from musculoskeletal complaints (including back pain) requiring treatment in the last 6 weeks, resulting in consultation with a physician and who have been treated with prescription drugs, physiotherapy, osteopathy, or other remedies.
3. subjects who report pain while walking on the agreed examination date, which is of intensity > 0 on the Numerical Rating Scale (NRS).
4. subjects who have had spinal surgery (nucleotomy, spondylodesis, etc.) and/or pelvic surgery in their past life, or have had severe pelvic and/or back disease/injury (discectomy, vertebral fracture, pelvic fracture, etc.).
5. subjects who participate in disability sports.
6. subjects whose walking speed and resulting walking distance are limited. Verification will be done in the context of a 2-minute walking test. There will be
a. female subjects excluded from study participation if the achieved walking distance after 2 minutes is <180.8m.
b. male subjects excluded from study participation if the achieved walking distance after 2 minutes is <197.2m.
7. subjects whose large joints of the lower and upper extremities have limitations in active range of motion. Range of motion will be assessed with a goniometer using the neutral zero method. Subjects will be excluded from study participation if, in the upright standing position (data in degrees):
a. Hip extension/flexion: =20/0/25.
b. Hip abduction/adduction: =5/0/10.
c. Hip internal rotation/external rotation: =5/0/10.
d. Knee extension/flexion: =0/0/60
e. OSG dorsiflexion/plantarflexion: =10/0/15.
f. Shoulder extension/flexion: =20/0/25
g. Elbow extension/flexion: =0/20/45.
8. subjects whose spinal mobility is limited. Range of motion will be verified through the use of a plurimeter. Subjects will be excluded from study participation if
a. ROM in the frontal plane re/li: =10/0/10.
b. ROM in the transverse plane re/li: =10/0/10.
9. subjects who take >12 seconds to complete the timed-up-and-go test (TUG) on the agreed examination date.
10. subjects who achieve a test score of = 2 points on the Back Performance Scale (BPS) test administration.
11. subjects who have back contour changes due to large scars, tumors, or due to tattoos in the measurement area.
12. subjects who have a BMI > 30 kg/m² on the agreed examination date.
13. subjects who have taken painkillers on the agreed examination date.
14. subjects suffering from cold symptoms (cough, fever, etc.) on the agreed examination date, have a confirmed COVID-19 disease.
15. subjects who have had a deliberate contact with a positively tested COVID-19 patient or have been in a risk area declared by the Robert Koch Institute in the two weeks prior on the agreed examination date.
16. subjects suffering from an acute medical condition, such as dizziness, nausea, balance disorders, or injury, on the day of the agreed examination date.
17. subjects who are not fully capable of consent or understanding on the agreed examination date.
18. subjects who are pregnant on the agreed examination date.
19. subjects who suffer from fluctuating disease processes (e.g. multiple sclerosis).
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the variance of the timing of maximum pelvic rotation in relation to the standardized gait cycle using videorasterstereography. Determination of the ratio of the variance of competitive athletes to that of healthy subjects in the general population.
- Secondary Outcome Measures
Name Time Method Comparison of the variance of the cohort of runners with the cohort of the other sports disciplines.